I think all of you would agree...most biotechs have benefitted from a "Halo Effect...during this Pandemic/Endemic....with so much focus on cures, fixes, and of course Mono Antibodies. We started with HIV...as the target indication...and now we are immersed in several other indications. I feel we are better off.. (save the PPS) than ever before in our history. With the top dozen or so Big Pharma companies having more than $170 Billion in excess RESERVES...the prospects for further financing and deal-making look ever more promising....Did I mention?.. we have a Platform Molecule...that actually works...at this point in the game...load up...when you can. The return is too great to ignore.